Everlywell

Austin, United States Founded: 2014 • Age: 12 yrs Unicorn
At-home health tests for biomarkers, nutrition, and hormone analysis.

About Everlywell

Everlywell is a Healthcare company based in Austin (United States) founded in 2014 by Julia Cheek. At-home health tests for biomarkers, nutrition, and hormone analysis. It operates on a D2C and Subscription model. Everlywell has raised $330 million across 7 funding rounds from investors including BlackRock, StepStone Group and NextGen Venture Partners. The company has 336 employees. Everlywell has completed 3 acquisitions, including Everlywell, Home Access and PWN Health. Everlywell was last valued at $1.3 billion in January 2021. Its chief executive, as recorded, is Julia Cheek. Its website everlywell.com draws about 574 thousand monthly visits. Everlywell offers products and services including Food Sensitivity Test, Women's Health Test, Metabolism Test, Thyroid Test, and Everlywell 360. Its focus areas include Wellness Tech, Nutritional Health, Food Sensitivity Testing and Diagnostic Tech. Its competitors include Viome, Color and Invitae; 3 of its 3 listed competitors have raised funding.

Company details

Everlywell provides direct-to-consumer at-home lab tests that measure biomarkers for areas like nutrition, hormones, and immune health. Users collect samples at home, receive actionable results, and access virtual consultations for personalized guidance. The service includes options for womens and mens health, with a focus on preventive care and easy online ordering. No specific location is mentioned, and it serves individual consumers seeking wellness insights.

  • Headquarters Austin, United States
  • Employees 336
  • Founders Julia Cheek
  • Stage Unicorn
  • Sectors
    Healthcare
  • Website category Health
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website everlywell.com
  • Social LinkedIn X Facebook Instagram
Key Metrics
  • Total Equity Funding
    $330M (USD)

    in 7 rounds

  • Latest Funding Round
    $75M (USD), Series D

    Jan 2021

  • Investors
    BlackRock

    & 19 more

  • Employee Count
    336
  • Investments & Acquisitions
    Everlywell

    & 2 more

Products & Services of Everlywell

Everlywell offers a comprehensive portfolio of products and services, including Food Sensitivity Test, Women's Health Test, Metabolism Test, Thyroid Test, and Everlywell 360.

Food Sensitivity Test
Diagnostic Tool

Tests IgG reactivity to foods for dietary insights.

Women's Health Test
Hormone Analysis

Measures biomarkers for women's overall health and wellness.

Metabolism Test
Hormone Testing

Evaluates hormones affecting weight and energy levels.

Thyroid Test
Endocrine Testing

Assesses thyroid hormones and antibodies for health monitoring.

Everlywell 360
Comprehensive Testing

Analyzes 83 biomarkers for personalized health insights.

Funding Insights of Everlywell

Everlywell has successfully raised a total of $330M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $330M
  • Total Rounds 7
  • Last Round Series D β€” $75M
  • First Round $2.5M

    (Apr 2016)

  • Investors Count 15

All 7 funding rounds of Everlywell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$75MSeries D$1.3BHealth Quest Capital
–
Dec 2020$175MSeries D–BlackRock, TCG
Feb 2020$25MSeries C–Highland Capital Partners
–
Apr 2019$50MSeries B–Goodwater Capital, Highland Capital Partners
May 2017$2MSeed–NextGen Venture Partners
Jun 2016$500,000Seed––
–
Apr 2016$2.5MSeed––
–
Valuation history
DateValuationStage
Jan 2021$1.3Bβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.3B (Jan 2021). 20 investors in total: 19 institutional and 1 angel.

Investors in Everlywell

Everlywell has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BlackRock, StepStone Group and NextGen Venture Partners.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investments are focused on tech and life sciences startups.
healthquestcapital.comBelmont, United States
Multi-stage investment firm invests in healthcare and life sciences companies
foresitecapital.comNew York, United States
Diversified investment management firm
2000greenspringassociates.comOwings Mills, United States
Seed and early-stage technology companies are funded by Lux Capital.
luxcapital.comMenlo Park, United States
Venture capital firm creating funds for innovative companies in women's health and emerging markets.
portfolia.co
Investments in consumer tech sectors are managed by Goodwater Capital.
goodwatercap.comBurlingame, United States
Multiple sectors are invested in by Morningside, a VC fund.
morningside.comNewton, United States
Early-stage technology companies are invested in via thematic research.
nextcoastventures.comAustin, United States
Venture capital investment and entrepreneur support services.
hcp.com
Venture capital investments are directed toward multiple sectors.
2011nextgenvp.comBaltimore, United States
Premium access

Investor details for Everlywell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Everlywell

2 people are tracked at Everlywell (2 in leadership); the tracked headcount is 336.

NameRoleGroup
Julia Cheek
Founder, CEOLeadership
Blake Lusenhop
Vice President Of EngineeringLeadership
Premium access

Complete people profiles for Everlywell

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Everlywell

Everlywell has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Everlywell, Home Access and PWN Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
At-home health testing solutions are provided by Everlywell.
natalist.comCharleston, United States2018Oct 2021β€’β€’β€’β€’
Population health and clinical genomic screening solutions are provided.
pwnhealth.comNew York, United States2015Mar 2021β€’β€’β€’β€’
Diagnostic & wellness tests company collecting sample through a kit
homeaccess.comHoffman Estates, United States1996Mar 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Everlywell

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Everlywell

7 dated milestones of Everlywell across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Everlywell is founded.
  2. Funding First funding round of $2.5M.
  3. Funding Latest funding round, Series D, of $75.0M.
  4. Milestone Reaches Unicorn status.
  5. Acquisition Acquires PWN Health.
  6. Acquisition Acquires Home Access.
  7. Acquisition Acquires Everlywell.

Competitors of Everlywell

Everlywell has 3 listed competitors in our database, 3 of them funded. They include Viome, Color and Invitae.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viome.com2016Los Alamos, United States$301.57M136
Machine learning-based bioinformatics solutions for health insights are provided.
color.com2013Burlingame, United States$491.44M687
Cancer care is delivered through a virtual clinic by Color.
invitae.com2010San Francisco, United States$189.56M1,700
Home-based genetic tests for detecting diseases are provided to individuals.
Premium access

Detailed competitors of Everlywell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Everlywell

The website of Everlywell (everlywell.com) receives about 574.3K visits a month and ranks #95,397 among all websites worldwide, #2,737 in Health.

  • Monthly visits
    574.3K

    ▲ 8% vs previous month

  • Unique visitors
    324.8K

    per month

  • Global rank
    #95,397

    among all websites

  • Category rank
    #2,737

    Health · Health

Similar websites

Websites whose visitors overlap most with Everlywell. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
letsgetchecked.com
100%
323.3K#109,638View details
ihealthlabs.com
94%
148.7K#285,508View details
lifedna.com
90%
116.1K#291,657View details
everwell.com
89%
7.6KView details
mylabbox.com
82%
65.3K#554,610View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 35 similar websites and full traffic analytics for Everlywell

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 35 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diagnostics & Lab Tech

3 companies that operate in the same segment as Everlywell (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Blood testing services are offered using finger-prick microsamples.
2017Austin, Texas, United StatesUSD 37.7 M
Manufactures clinical diagnostic test kits
1971Irvine, California, United StatesUSD 4.45 M54
Manufacturer of Laboratory equipment
1955Norwood, Massachusetts, United States
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Everlywell

Premium access

Complete news archive for Everlywell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Everlywell

Everlywell was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Everlywell is headquartered in Austin, United States. It is registered at Austin, Texas, United States.

Julia Cheek is the CEO of Everlywell, as recorded in our data. They have also founded this company.

Everlywell is a funded company, having raised a total of $330M across 7 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on Apr 2016.

Everlywell has 336 employees.

Everlywell provides direct-to-consumer at-home lab tests that measure biomarkers for areas like nutrition, hormones, and immune health. Users collect samples at home, receive actionable results, and access virtual consultations for personalized guidance. The service includes options for womens and mens health, with a focus on preventive care and easy online ordering. No specific location is mentioned, and it serves individual consumers seeking wellness insights.

Everlywell's top competitors include Viome, Invitae and Color.

Everlywell offers Food Sensitivity Test, Women's Health Test, Metabolism Test, Thyroid Test, and Everlywell 360.

Everlywell has made 3 acquisitions, including Everlywell, Home Access, and PWN Health.

Everlywell has 20 investors. Key investors include BlackRock, StepStone Group, NextGen Venture Partners, TCG Ventures, and Greenspring Associates.

The valuation of Everlywell is $1.3B as of Jan 2021.

The website of Everlywell receives about 574 thousand visits a month and ranks #95,397 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available